Professional
Added to YB: 2025-01-07
Pitch date: 2025-01-06
SRT.F [bullish]
Sartorius Aktiengesellschaft
+6.5%
current return
Author Info
No bio for this author
Company Info
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers.
Market Cap
EUR 11.7B
Pitch Price
EUR 177.85
Price Target
N/A
Dividend
0.39%
EV/EBITDA
21.83
P/E
154.33
EV/Sales
4.91
Sector
Life Sciences Tools and Services
Category
growth
Sartorius Q4 2024: JPMorgan Forecasts Solid Revenue Growth and Profitable EBITDA Performance
SRT.F: JPM expects €705m BPS orders in Q4'24 (+14% QoQ), driven by strong consumables demand offsetting weak equipment orders. Forecasts solid CER revenue growth, profitable EBITDA growth for 2025. Places SRT/DIM on Positive Catalyst Watch for Q4 results (Jan 28), expecting EBITDA beat & achievable 2025 guidance.
Read full article (2 min)